27% Cheaper Than Buffett’s Buy – And Sitting on a Key Zone

Hi,
One of the most recent and notable additions to Berkshire Hathaway’s portfolio is Constellation Brands
STZ — and if that’s not a fundamental vote of confidence, I don’t know what is.
And hey, while Midsummer Day is behind us, warm and sunny summer evenings still lie ahead. So why not make your next cold Corona or Modelo a bit more... eemmm... financially meaningful? 😄
Because let’s be honest, I’m not just sipping beer, I’m making strategic support buys to help lift the chart. 🍻 That’s right, not a simple toast but a tactical entry. Cheers to price action! ;)
Okay, jokes aside, but technically, this stock is now sitting at a real make-or-break level that deserves attention.
Technical View:
--------------------------------------------------------
Now add this:
You’re not just buying a chart level. You’re buying a premium cash generator:
- FCF Yield ~6.8%
- Operating margin ~34%
- Trading ~27% cheaper than Berkshire’s initial average (their cost basis is around $220/share)
- Strong brands, stable cash flows, and pricing power
Yes, last earnings had a one-off impairment but the underlying business remains rock solid.
If you’ve ever wanted to justify those "cold snacks" in your hand as “portfolio research”... well, here’s your excuse.
Do your homework, this might be your stock today.
Cheers🍻
Vaido
One of the most recent and notable additions to Berkshire Hathaway’s portfolio is Constellation Brands
And hey, while Midsummer Day is behind us, warm and sunny summer evenings still lie ahead. So why not make your next cold Corona or Modelo a bit more... eemmm... financially meaningful? 😄
Because let’s be honest, I’m not just sipping beer, I’m making strategic support buys to help lift the chart. 🍻 That’s right, not a simple toast but a tactical entry. Cheers to price action! ;)
Okay, jokes aside, but technically, this stock is now sitting at a real make-or-break level that deserves attention.
Technical View:
- Trendline — We’re seeing the third touch, which tends to be the strongest. I usually ignore wicks, but this time the confluence gives it weight.
- Monthly EMA200 — Last touched during the 2008/2009 crash. A level packed with long-term liquidity and psychological weight.
- Fibonacci 38% retracement
- Horizontal support — Marked by arrows on the chart. Price has reversed here multiple times. It’s not a coincidence and hopefully this time isn’t the exception.
- $150 mid-round level — US markets love round numbers, and this one sits right inside the box. Often a magnet for liquidity and reaction.
--------------------------------------------------------
Now add this:
You’re not just buying a chart level. You’re buying a premium cash generator:
- FCF Yield ~6.8%
- Operating margin ~34%
- Trading ~27% cheaper than Berkshire’s initial average (their cost basis is around $220/share)
- Strong brands, stable cash flows, and pricing power
Yes, last earnings had a one-off impairment but the underlying business remains rock solid.
If you’ve ever wanted to justify those "cold snacks" in your hand as “portfolio research”... well, here’s your excuse.
Do your homework, this might be your stock today.
Cheers🍻
Vaido
🔍I do the technicals - so You don’t have to.
📊Follow my research on Substack:
👉vaido.substack.com/ - ENG
👉vaidoveek.substack.com/ - EST
🚀 Actionable market analysis, ideas, and education
📊Follow my research on Substack:
👉vaido.substack.com/ - ENG
👉vaidoveek.substack.com/ - EST
🚀 Actionable market analysis, ideas, and education
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🔍I do the technicals - so You don’t have to.
📊Follow my research on Substack:
👉vaido.substack.com/ - ENG
👉vaidoveek.substack.com/ - EST
🚀 Actionable market analysis, ideas, and education
📊Follow my research on Substack:
👉vaido.substack.com/ - ENG
👉vaidoveek.substack.com/ - EST
🚀 Actionable market analysis, ideas, and education
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.